KORU Medical Systems, Inc. (KRMD) Stock Forecast
KRMD analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 4 analysts
- Price target
- $6.25 average of analyst targets
- Upside to target
- +108.3% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $0.00
- 52-week range
- $2.93 – $6.52
KRMD analyst ratings
4 analystsNumber of analysts at each rating.
KRMD price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
KRMD earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.02 | −$0.02 | −$0.02 | $0.00 | 0.0% | 2 |
| Current fiscal year (2026) | −$0.01 | −$0.01 | $0.00 | $0.01 | −150.0% | 2 |
| Next fiscal year (2027) | $0.04 | $0.02 | $0.05 | −$0.01 | +800.0% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
KRMD revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $11.3M | $11.3M | $11.4M | +8.9% | 4 |
| Current fiscal year (2026) | $48.0M | $47.8M | $48.3M | +16.8% | 4 |
| Next fiscal year (2027) | $56.3M | $54.6M | $58.1M | +17.2% | 4 |
KRMD EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
KRMD revenue: reported and forecast
KRMD EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.01 | $0.01 | $0.01 | $0.01 | −$0.02 | −500.0% | 0 up · 1 down |
| Current fiscal year (2026) | $0.02 | $0.02 | $0.02 | $0.02 | −$0.01 | −125.0% | 0 up · 0 down |
| Next fiscal year (2027) | $0.08 | $0.08 | $0.08 | $0.08 | $0.04 | −56.2% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
KRMD earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; KRMD beat in 11 of 12.
What analysts expect from KRMD
4 analysts cover KORU Medical Systems; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $6.25, 108.3% above the latest close of $3.00. Analysts expect earnings of −$0.01 per share for 2026, −150.0% from a year earlier. For 2027 the average estimate is $0.04 per share on revenue of $56.3 million. KORU Medical Systems beat the EPS estimate in 11 of the last 12 quarters.
Related: KRMD income statement, KRMD key metrics, KRMD chart. See the KRMD stock overview for the latest quote and news.
KRMD forecast FAQ
What is KORU Medical Systems's price target?
The average analyst price target for KORU Medical Systems is $6.25, 108.3% above the latest close of $3.00.
Is KORU Medical Systems a buy, hold or sell?
Of 4 analysts covering KORU Medical Systems, 3 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is KORU Medical Systems's EPS forecast?
Analysts forecast −$0.01 per share for 2026 (range −$0.01 to $0.00); for 2027 the estimate is $0.04.
What is KORU Medical Systems's revenue forecast?
The average revenue estimate for 2026 is $48.0 million, growth of 16.8%; for 2027 it is $56.3 million.
When does KORU Medical Systems report earnings?
KORU Medical Systems is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes; the EPS estimate is $0.00.
Does KORU Medical Systems usually beat earnings estimates?
KORU Medical Systems reported EPS at or above the analyst estimate in 11 of the last 12 quarters.